Rani Therapeutics Inc.

NASDAQ: RANI · Real-Time Price · USD
0.55
-0.01 (-1.22%)
At close: Aug 15, 2025, 3:58 PM
0.55
0.00%
After-hours: Aug 15, 2025, 07:04 PM EDT

Rani Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.3 -2.49 -2.22 -38.69
PEG Ratio
0.06 -0.64 -0.01 0.76
PS Ratio
37.95 n/a n/a 118.62
PB Ratio
19.58 6.58 3.81 6.80
P/FCF Ratio
-1.09 -1.61 -2.92 -9.84
P/OCF Ratio
-1.1 -1.65 -3.02 -10
OCF/S Ratio
-34.53 n/a n/a -11.87
Debt / Equity Ratio
14.91 2.34 0.82 n/a
Quick Ratio
1.50 6.36 20.96 45.30
Current Ratio
1.50 6.36 20.96 45.30
Asset Turnover
0.03 n/a n/a 0.02
Interest Coverage
-10.59 -13 -59.24 -110.73
Return on Equity
-15.07 -2.64 -1.72 -0.18
Return on Assets
-0.82 -0.59 -0.59 -0.07
Return on Invested Capital
-3.03 -1.19 -0.6 -0.42
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 n/a n/a 1.00
Net Profit Margin
-29.2 n/a n/a -3.07
Pretax Profit Margin
-29.2 n/a n/a -19.52
Operating Profit Margin
-51.86 n/a n/a -18.99
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-49.15 n/a n/a -19.17